The Impact of Body Mass Index on Pathological Response and Survival Outcome after Neoadjuvant Chemotherapy in Localized Bladder Cancer.
Background: Neoadjuvant chemotherapy (NAC) grants a modest survival benefit in localized muscle-invasive bladder cancer (MIBC). We evaluated the pathological response and survival outcome after NAC in stage II and IIIA MIBC and their correlation with body mass index (BMI). Method: Our retrospective...
| Publicado en: | Middle East Journal of Cancer Vol. 14; no. 1; pp. 136 - 146 |
|---|---|
| Autores principales: | , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Middle East Journal of Cancer
Jan2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |